Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 10.
doi: 10.1007/s11302-024-10054-7. Online ahead of print.

P2 purinergic receptor expression and function in tumor-related immune cells

Vahinipriya Manoharan  1 , Oluwafemi O Adegbayi  1 , Janielle P Maynard  2   3
Affiliations
Review

P2 purinergic receptor expression and function in tumor-related immune cells

Vahinipriya Manoharan et al. Purinergic Signal. .

Abstract

P2 purinergic receptor expression is dysregulated in multiple cancer subtypes and is associated with worse outcomes. Studies identify roles for P2 purinergic receptors in tumor cells that drive disease aggressiveness. There is also sufficient evidence that P2 purinergic receptor expression within the tumor microenvironment (TME) is critical for disease initiation and progression. Immune cells constitute a significant component of the TME and display both tumorigenic and anti-tumorigenic potential. Studies pre-dating the investigation of P2 purinergic receptors in cancer identify P2 receptor expression on multiple immune cells including macrophages, neutrophils, T-cells, and dendritic cells; all of which are implicated in tumor initiation, tumor promotion, or response to treatment. Herein, we discuss P2 purinergic receptor expression and function in tumor-related immune cells. We provide a rationale for further investigations of P2 purinergic receptors within the TME to better define the mechanistic pathways of inflammation-mediate tumorigenesis and explore P2 purinergic receptors as potential targets for novel immunotherapeutic approaches.

Keywords: Immune cells; Macrophages; Neutrophils; P2 purinergic receptor; T-cells; Tumor microenvironment.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:162 - PubMed - PMC - DOI
    1. Burnstock G (2018) Purine and purinergic receptors. Brain Neurosci Adv 2:2398212818817494 - PubMed - PMC - DOI
    1. Sarikaya E (2019) Functions of purinergic receptors. In Receptors P1 and P2 as targets for drug therapy in humans, IntechOpen: 2019
    1. da Silva Ferreira NC, Alves LA, Soares-Bezerra RJ (2019) Potential therapeutic applications of P2 receptor antagonists: from bench to clinical trials. Curr Drug Targets 20:919–937 - PubMed - DOI
    1. Maynard JP, Sfanos KS (2022) P2 purinergic receptor dysregulation in urologic disease. Purinergic Signal 18:267–287 - PubMed - PMC - DOI

LinkOut - more resources